Otsuka Pharmaceutical Co., Ltd. et al v. Zenara Pharma Private Ltd. et al

Docket(#10) Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 10/21/2022)

DocketCASE CLOSED (See D.I. 593 in lead case no. 19cv1938-LPS) Associated Cases: 1:20-cv-01599-LPS, 1:22-cv-01269-LPS (ntl) (Entered: 10/21/2022)

DocketCase associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl) (Entered: 10/20/2022)

DocketSO ORDERED, re (588 in 1:19-cv-01938-LPS, 9 in 1:22-cv-01269-LPS) STIPULATED ORDER Seeking Consolidation of Actions filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 10/20/22. Associated Cases: 1:19-cv-01938-LPS, 1:22-cv-01269-LPS (ntl) (Entered: 10/20/2022)

Docket(#9) STIPULATION Seeking Consolidation of Actions, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 10/19/2022)

Docket(#8) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biophore India Pharmaceuticals Private Ltd. for Zenara Pharma Private Ltd. filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth) (Entered: 10/07/2022)

Docket(#7) ANSWER to #1 Complaint, by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth) (Entered: 10/07/2022)

DocketCase Reassigned to Judge Leonard P. Stark of the United States Court of Appeals for the Federal Circuit (due to prior related cases). Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) (Entered: 10/05/2022)

DocketCase Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 10/05/2022)

DocketNo Summons Issued. (apk) (Entered: 09/28/2022)

Docket(#6) Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H Lundbeck A/S. (apk) (Entered: 09/28/2022)

Docket(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (apk) (Entered: 09/28/2022)

Docket(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE,48,059 ;8,349,840 ;8,618,109 ;9,839,637 ;10,307,419. (apk) (Entered: 09/28/2022)

Docket(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/19/2022. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 1/10/2023. (apk) (Entered: 09/28/2022)

Docket(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 09/28/2022)

Docket(#1) COMPLAINT FOR PATENT INFRINGEMENT filed against Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd. ( Filing fee $ 402, receipt number ADEDC-3969147.) - filed by Otsuka Pharmaceutical Co., Ltd., H Lundbeck A/S. (Attachments: #1 Exhibit A-G, #2 Civil Cover Sheet)(apk) (Entered: 09/28/2022)